Dennis M. Lanfear
President & CEO at Coherus Oncology Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Coherus Oncology Inc., 3 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 23, 2026 | Coherus Oncology Inc. | Grant or award | +375,000 | — | — |
| Jan 20, 2026 | Coherus Oncology Inc. | Shares withheld for tax | −11,839 | $1.55 | $18,350 |
| Jan 20, 2025 | Coherus Oncology Inc. | Shares withheld for tax | −11,810 | $1.39 | $16,416 |
| Jan 4, 2025 | Coherus Oncology Inc. | Shares withheld for tax | −11,810 | $1.66 | $19,605 |
| Jan 20, 2024 | Coherus Oncology Inc. | Shares withheld for tax | −11,218 | $2.44 | $27,372 |
| Jan 4, 2024 | Coherus Oncology Inc. | Shares withheld for tax | −11,781 | $2.92 | $34,401 |
| Nov 22, 2023 | Coherus Oncology Inc. | Option exercise | +41,000 | $1.42 | $58,220 |
| Nov 22, 2023 | Coherus Oncology Inc. | Option exercise | +258,940 | $1.42 | $367,695 |
| Nov 22, 2023 | Coherus Oncology Inc. | Open-market sale | −223,100 | $2.02 | $450,662 |
| Jan 20, 2023 | Coherus Oncology Inc. | Grant or award | +86,250 | — | — |
| Jan 4, 2023 | Coherus Oncology Inc. | Shares withheld for tax | −10,905 | $9.87 | $107,632 |
| Dec 30, 2022 | Coherus Oncology Inc. | Gift | −4,000 | — | — |
Questions about Dennis M. Lanfear
What boards is Dennis M. Lanfear on?
Dennis M. Lanfear sits on the board of Coherus Oncology Inc.
What company is Dennis M. Lanfear the CEO of?
Dennis M. Lanfear is President & CEO of Coherus Oncology Inc.
How long has Dennis M. Lanfear served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.